⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RARE News
Ultragenyx Pharmaceutical Inc.
RARE DEADLINE NOTICE: ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages Ultragenyx Pharmaceutical Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RARE
accessnewswire.com
RARE
Ultragenyx Pharmaceutical Inc. Notice of April 6, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
accessnewswire.com
RARE
Pomerantz LLP Updates Shareholders on Legal Action Brought Against Ultragenyx Pharmaceutical Inc. – RARE
accessnewswire.com
RARE
RARE CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Ultragenyx Pharmaceutical (RARE) Investors of Securities Class Action Deadline on April 6, 2026 Ready to Announce with Confidence?
newsfilecorp.com
RARE
Levi & Korsinsky, LLP: Rare Stock Loss Quantifies Investor Damages Following Phase III Study Failure Disclosure
globenewswire.com
RARE
INVESTOR DEADLINE: Ultragenyx Pharmaceutical Inc. (RARE) Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit - RGRD Law
globenewswire.com
RARE
RARE Investors Have Opportunity to Lead Ultragenyx Pharmaceutical Inc. Securities Fraud Lawsuit with the Schall Law Firm
globenewswire.com
RARE
Pomerantz LLP Reminds Shareholders: Securities Lawsuit Has Been Filed Against Ultragenyx Pharmaceutical Inc. – RARE
accessnewswire.com
RARE
RARE INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Ultragenyx Pharmaceutical Inc. Investors Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
RARE
Pomerantz LLP Updates Investors on Legal Action Brought Against Ultragenyx Pharmaceutical Inc. – RARE
accessnewswire.com
RARE